Singapore markets closed

Savara Inc. (SVRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.9800+0.1300 (+2.68%)
At close: 04:00PM EDT
5.0000 +0.02 (+0.40%)
After hours: 07:45PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.8500
Open4.8800
Bid4.9400 x 200
Ask5.0300 x 100
Day's range4.8450 - 4.9900
52-week range1.6300 - 5.7000
Volume904,198
Avg. volume824,867
Market cap687.977M
Beta (5Y monthly)0.77
PE ratio (TTM)N/A
EPS (TTM)-0.3300
Earnings date13 May 2024 - 17 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.79
  • Business Wire

    Savara Announces New Employment Inducement Grant

    AUSTIN, Texas, March 22, 2024--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees.

  • Business Wire

    Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update

    LANGHORNE, Pa., March 07, 2024--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the fourth quarter and full year ending December 31, 2023 and provided a business update.

  • Business Wire

    Savara to Present at the Barclays 26th Annual Global Healthcare Conference

    LANGHORNE, Pa., March 06, 2024--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on March 14, 2024 at 5:00am PT/8:00am ET. A live webcast of the fireside chat will be available on Savara’s website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days.